None
Quote | Predictive Oncology Inc. (NASDAQ:POAI)
Last: | $1.17 |
---|---|
Change Percent: | 1.64% |
Open: | $1.2 |
Close: | $1.17 |
High: | $1.22 |
Low: | $1.16 |
Volume: | 90,724 |
Last Trade Date Time: | 06/17/2024 03:00:00 am |
News | Predictive Oncology Inc. (NASDAQ:POAI)
Predictive Oncology (NASDAQ: POAI) , a leader in AI-driven drug discovery and biologics, today announced the introduction of a new technology designed to express functional and stable G-Protein Coupled Receptors (“GPCRs”). GPCRs are cell surface membrane receptors believed to play a...
Company files expansive intellectual property protection for “Membrane Protein Factory” to produce purified and biologically active membrane proteins for drug development External sources value annual US GPCR market at nearly $3.5 billion in 2022, growing more than 5% annu...
Message Board Posts | Predictive Oncology Inc. (NASDAQ:POAI)
Subject | By | Source | When |
---|---|---|---|
This will be back below a dollar sooner | Distantpulse | investorshub | 04/26/2023 9:51:16 PM |
I blame it on AI. First $POAI did | 77Port | investorshub | 04/24/2023 7:00:51 PM |
There will be a lawsuit and we will | Distantpulse | investorshub | 04/24/2023 3:10:26 PM |
$POAI: new motto. We destroy shareholders to | 77Port | investorshub | 04/24/2023 2:16:09 PM |
$POAI is now VERY thin GREEEN we come | knrorrel | investorshub | 04/18/2023 2:26:35 PM |
News, Short Squeeze, Breakout and More Instantly...
Predictive Oncology Inc. Company Name:
POAI Stock Symbol:
NASDAQ Market:
Predictive Oncology (NASDAQ: POAI) , a leader in AI-driven drug discovery and biologics, today announced the introduction of a new technology designed to express functional and stable G-Protein Coupled Receptors (“GPCRs”). GPCRs are cell surface membrane receptors believed to play a...
Company files expansive intellectual property protection for “Membrane Protein Factory” to produce purified and biologically active membrane proteins for drug development External sources value annual US GPCR market at nearly $3.5 billion in 2022, growing more than 5% annu...
Predictive Oncology (NASDAQ: POAI) , a leader in AI-driven drug discovery and biologics, today announced the availability of its unique 3D cell culture model to advance cancer drug discovery and enable future drug development. More closely mimicking human tissue architecture than traditional 2D a...